Gender-Associated Differences in Lung Cancer: Clinical Characteristics and Treatment Outcomes in Women

被引:44
作者
Harichand-Herdt, Seema [1 ]
Ramalingam, Suresh S. [1 ]
机构
[1] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA
关键词
SEX-ASSOCIATED DIFFERENCES; PROGNOSTIC-FACTORS; ESTROGEN-RECEPTOR; FEMALE-PATIENTS; PHASE-III; SURVIVAL; GEFITINIB; EPIDEMIOLOGY; CHEMOTHERAPY; PLUS;
D O I
10.1053/j.seminoncol.2009.10.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is the leading cause of cancer deaths in the United States. In recent years the incidence of lung cancer in men has been declining, while in women it has been increasing. A number of population-based studies have demonstrated gender-based differences in clinical and pathologic factors, as well as in survival related to lung cancer. Disparities in age, smoking practices, and histological subtypes are among the differences that have been identified. Gender disparity also has been observed in outcomes, with improved survival observed for women in a number of clinical trials. This article reviews the gender-related differences in clinical and pathologic factors and outcomes of patients with lung cancer observed in population-based studies and clinical trials. Semin Oncol 36:572-580 (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:572 / 580
页数:9
相关论文
共 52 条
[11]   Sex-associated differences in survival of patients undergoing resection for lung cancer [J].
Ferguson, MK ;
Wang, J ;
Hoffman, PC ;
Haraf, DJ ;
Olak, J ;
Masters, GA ;
Vokes, EE .
ANNALS OF THORACIC SURGERY, 2000, 69 (01) :245-249
[12]   ANTI-ANGIOGENESIS - NEW CONCEPT FOR THERAPY OF SOLID TUMORS [J].
FOLKMAN, J .
ANNALS OF SURGERY, 1972, 175 (03) :409-&
[13]   Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group [J].
Fossella, F ;
Pereira, JR ;
von Pawel, J ;
Pluzanska, A ;
Gorbounova, V ;
Kaukel, E ;
Mattson, KV ;
Ramlau, R ;
Szczesna, A ;
Fidias, P ;
Millward, M ;
Belani, CP .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3016-3024
[14]   Lung cancer in women - Analysis of the national surveillance, epidemiology, and end results database [J].
Fu, JB ;
Kau, TY ;
Severson, RK ;
Kalemkerian, GP .
CHEST, 2005, 127 (03) :768-777
[15]   Hormone replacement therapy is associated with decreased survival in women with lung cancer [J].
Ganti, AK ;
Sahmoun, AE ;
Panwalkar, AW ;
Tendulkar, KK ;
Potti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :59-63
[16]   Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database [J].
Govindan, Ramaswamy ;
Page, Nathan ;
Morgensztern, Daniel ;
Read, William ;
Tierney, Ryan ;
Vlahiotis, Anna ;
Spitznagel, Edward L. ;
Piccirillo, Jay .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) :4539-4544
[17]  
GUO NL, 2009, LUNG CANC
[18]   Review of epidermal growth factor receptor biology [J].
Herbst, RS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02) :21-26
[19]   Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer [J].
Hirsch, Fred R. ;
Varella-Garcia, Marileila ;
Bunn, Paul A., Jr. ;
Franklin, Wilbur A. ;
Dziadziuszko, Rafal ;
Thatcher, Nick ;
Chang, Alex ;
Parikh, Purvish ;
Rodrigues Pereira, Jose ;
Ciuleanu, Tudor ;
von Pawel, Joachim ;
Watkins, Claire ;
Flannery, Angela ;
Ellison, Gillian ;
Donald, Emma ;
Knight, Lucy ;
Parums, Dinah ;
Botwood, Nicholas ;
Holloway, Brian .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) :5034-5042
[20]   Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non-Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine [J].
Holm, Bente ;
Mellemgaard, Anders ;
Skov, Torsten ;
Skov, Birgit Guldhammer .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4254-4259